Scotland business

US life sciences firm BioClavis sets up base in Glasgow

screen grab from BioSpyder website Image copyright BioSpyder

A US-owned cancer diagnostics specialist is setting up a new base in Glasgow, creating more than 40 jobs.

BioClavis, which is a spin-out from Californian molecular profiling company BioSpyder, will be located at the Queen Elizabeth University Hospital.

The move is part of a £10.5m investment supported by Scottish Enterprise.

The announcement came during a visit by Economy Secretary Keith Brown to the US and Canada, where he is promoting Scotland to business leaders.

Scottish Enterprise is providing a research and development grant of £4.5m towards the new business, which will work in close collaboration with the NHS and university researchers.

Mr Brown said: "This is an exciting time for life science businesses in Scotland. The sector is strong and continuing to grow - providing employment for over 37,000 people."

Joel McComb, chief executive of BioSpyder and BioClavis said: "We're very excited to build on the success we've had in other molecular profiling applications and bring this novel method to bear on discovery and deployment of next generation genomic diagnostics."

Related Internet links

The BBC is not responsible for the content of external Internet sites